Cassava Sciences Inc (SAVA)
2.34
-0.07
(-2.90%)
USD |
NASDAQ |
Dec 24, 16:00
Cassava Sciences Cash from Financing (Quarterly): 0.00 for Sept. 30, 2024
Cash from Financing (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Cash From Financing Definition
Cash flow from financing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall financing activities of the company. A few examples of financing activities include common stock issuance, total dividends paid, and net debt issuance.
Cash from Financing (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Financing (Quarterly) Benchmarks
| Bristol-Myers Squibb Co | -3.852B |
| BridgeBio Pharma Inc | 0.707M |
| Seelos Therapeutics Inc | 0.742M |
| Alnylam Pharmaceuticals Inc | 102.76M |
| EyePoint Pharmaceuticals Inc | 11.89M |
Cash from Financing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | -18.30M |
| Cash from Investing (Quarterly) | -0.017M |
| Free Cash Flow | -78.07M |
| Free Cash Flow Per Share (Quarterly) | -0.3817 |
| Free Cash Flow Yield | -73.94% |